Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Cardiac resynchronization therapy: Who benefits?
Jason S. Chinitz
, Andre D'Avila
,
Martin Goldman
, Vivek Reddy
,
Srinivas Dukkipati
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Cardiology
Research output
:
Contribution to journal
›
Review article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cardiac resynchronization therapy: Who benefits?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Baseline Severity
12%
Block Pattern
12%
Cardiac Function
12%
Cardiac Resynchronization Therapy
100%
Cardiac Structure
12%
Cardiomyopathy
12%
Clinical Trials
12%
Consensus Guidelines
12%
Current Guidelines
12%
Etiology
12%
Evolving Therapies
12%
Functional Capacity
12%
Functional Impairment
12%
Hemodynamic Profile
12%
Hospitalization
25%
Large Trials
12%
Left Bundle Branch Block
12%
Long-term Benefit
12%
Long-term Mortality
12%
Mortality Benefit
12%
New York Heart Association Class
25%
On-state Current
12%
Optimal Medical Therapy
12%
Patient Identification
12%
Patient Selection
25%
Patients with Heart Failure
12%
QRS Morphology
12%
QRS Prolongation
12%
Reverse Remodeling
12%
Sick
12%
Medicine and Dentistry
Antibradycardia Pacing
12%
Cardiac Resynchronization Therapy
100%
Cardiac Structure
12%
Clinical Trial
12%
Combination Therapy
12%
Congestive Heart Failure
12%
Functional Disease
12%
Functional Status
12%
Heart Function
12%
Hemodynamic
12%
Left Bundle Branch Block
12%
Myocardial Disease
12%
New York Heart Association Class
25%
Rhythm
12%